#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15336	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2603	725.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1740	1740	C	988	C,T	987,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15336	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2603	725.7	0	HET	.	.	.	C611T,G	.	611	611	C	1167	1167	C	905	C,T,G	686,217,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25362	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4004	789.1	0	.	n	.	0	T695C	SNP	695	695	T	1300	1300	C	931	C,T,G	928,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25362	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4004	789.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1942	1942	A	1068	A,C	1067,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25362	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4004	789.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2576	2576	C	846	C,T	845,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25362	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4004	789.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3202	3202	T	900	T,G	898,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25362	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4004	789.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2650	2650	A	791	A,T	790,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2334	folP	852	852	100.0	folP.l6.c4.ctg.1	2018	144.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1240	1242	AGC	228;225;225	A,G;G;C,A	226,2;225;224,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5644	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3869	181.9	1	SNP	p	S91F	0	.	.	271	273	TCC	777	779	TCC	216;216;215	T;C;C	216;216;215	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5644	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3869	181.9	1	SNP	p	D95G	0	.	.	283	285	GAC	789	791	GAC	210;208;206	G,A;A;C	209,1;208;206	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5644	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3869	181.9	1	SNP	p	D95N	0	.	.	283	285	GAC	789	791	GAC	210;208;206	G,A;A;C	209,1;208;206	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	2138	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1784	149.4	1	SNP	p	G45D	1	.	.	133	135	GAC	742	744	GAC	229;228;225	G;A;C,A	228;227;223,1	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1182	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1535	96.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5432	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3456	195.9	1	SNP	p	D86N	0	.	.	256	258	GAC	842	844	GAC	221;221;223	G;A,C;C	221;220,1;223	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5432	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3456	195.9	1	SNP	p	S87R	0	.	.	259	261	AGT	845	847	AGT	223;225;225	A;G;T	223;225;225	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5432	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3456	195.9	1	SNP	p	S87I	0	.	.	259	261	AGT	845	847	AGT	223;225;225	A;G;T	223;225;225	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5432	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3456	195.9	1	SNP	p	S87W	0	.	.	259	261	AGT	845	847	AGT	223;225;225	A;G;T	223;225;225	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5432	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3456	195.9	1	SNP	p	S88P	0	.	.	262	264	TCC	848	850	TCC	225;224;226	T,G;C;C	223,2;224;226	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4552	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3251	174.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1794	1796	GGC	239;238;237	G,T;G;C,G	237,2;238;236,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1431	1433	GCA	265;266;263	G,A,T;C,A;A	263,1,1;265,1;263	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1434	1436	ATC	264;262;261	A;T;C	264;262;261	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1446	1448	GTG	260;260;260	G;T;G,T	260;260;259,1	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1446	1448	GTG	260;260;260	G;T;G,T	260;260;259,1	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1950	1952	ACC	207;208;208	A,T,C;C;C	205,1,1;208;208	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2004	2006	GCG	195;200;201	G;C,T;G	195;199,1;201	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2004	2006	GCG	195;200;201	G;C,T;G	195;199,1;201	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2127	2129	GGC	206;207;207	G;G;C	206;207;207	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2136	2138	GGC	206;205;207	G;G;C,A	206;205;206,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4214	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2759	190.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2154	2156	CCG	214;214;216	C,G;C;G,C,T	212,2;214;212,3,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6048	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3556	211.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2878	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2332	154.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	850	850	C	208	C	208	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	626	628	GGA	231;232;232	G;G;A	231;232;232	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	V75I	NONSYN	223	225	GTT	707	709	ATT	245;245;244	A;T,A;T	245;244,1;244	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	749	751	AGC	232;234;235	A;G;C	232;234;235	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	V98I	NONSYN	292	294	GTC	776	778	ATC	232;232;228	A;T,G;C	232;231,1;228	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	841	842	CG	232;230	C;G,A	232;229,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	844	846	CAG	233;235;237	C;A,C;G	233;234,1;237	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	848	850	AAA	239;240;242	A;A;A	239;240;242	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	911	913	GAA	264;263;261	G;A;A,C	264;263;260,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	935	937	GCA	251;252;253	G,T;C;A	250,1;252;253	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1121	1123	TCA	260;257;258	T;C,T;A	260;256,1;258	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1241	1243	CAA	211;208;207	C;A;A,C	211;208;206,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	.	INDELS	760	762	ACA	1245	1249	ATCAA	203;203;200;200;200	A;T,G;C;A;A	203;202,1;200;200;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	.	INDELS	763	764	TG	1252	1254	AGT	204;205;206	A;G;T,G	204;205;205,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1259	1261	GAT	217;216;217	G;A;T	217;216;217	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1367	1369	AGT	258;258;260	A,C;G;T	257,1;258;260	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1373	1375	GAC	268;267;270	G,T;A;C	267,1;267;270	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1376	1378	TAC	272;275;276	T;A,T,C;C	272;273,1,1;276	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	1	SNP	p	G120K	1	.	.	358	360	AAG	841	843	CGG	232;230;231	C;G,A;G,A	232;229,1;230,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	1	SNP	p	A121D	1	.	.	361	363	GAC	844	847	CGC	233;237;239	C;G;C,G,A	233;237;237,1,1	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2850	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1666	207.0	1	SNP	p	D121N	0	.	.	361	363	GAC	844	847	CGC	233;237;239	C;G;C,G,A	233;237;237,1,1	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	258	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	56.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	74;74;74	A;C;T	74;74;74	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	258	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	56.4	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	74;74;74	A,C;G;T	73,1;74;74	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	258	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	56.4	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	74;74;74	G;A;C	74;74;74	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	258	porB3	990	162	93.83	porB3.l15.c30.ctg.1	164	56.4	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	74;74;74	T;A;C	74;74;74	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10294	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5392	238.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2258	2260	AAT	255;253;254	A,T,G;A,T;T,G	253,1,1;252,1;253,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1486	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1581	117.0	1	SNP	p	V57M	1	.	.	169	171	ATG	755	757	ATG	269;268;266	A;T,C;G,A	269;267,1;265,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
